# US 2012/0231048 A1 · Medical Devices and Implants from Nb-Ta-W-Zr Alloys

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0231048 A1
- Document ID: US20120231048A1
- Status: Published application
- Kind: A1
- Application number: 13/481,017
- Filed: 2012-05-25
- Published: 2012-09-13
- Earliest claimed: 2003-02-10
- Assignees: Heraeus Precious Metals GmbH & Co. KG
- Inventors: Jürgen WACHTER; Jens TRÖTZSCHEL; Randolf VON OEPEN
- Web page: https://patentgrep.com/patent/US20120231048A1

## CPC

- A61L 27/047: {Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 29/02: Inorganic materials
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 29/18: Materials at least partially X-ray or laser opaque
- A61L 31/022: {Metals or alloys}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 31/18: Materials at least partially X-ray or laser opaque
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- C22C 27/00: Alloys based on rhenium or a refractory metal not mentioned in groups C22C14/00 or C22C16/00
- C22C 27/02: Alloys based on vanadium, niobium, or tantalum
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- Y10T 428/12819: Group VB metal-base component
- Y10T 428/31678: Of metal
- Y10T 428/31681: Next to polyester, polyamide or polyimide [e.g., alkyd, glue, or nylon, etc.]
- Y10T 428/31703: Next to cellulosic
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention relates to a medical device or implant made at least in part of a high-strength, low-modulus metal alloy comprising niobium, tantalum, and at least one element selected from the group consisting of zirconium, tungsten, and molybdenum. The medical devices according to the present invention provide superior characteristics with regard to biocompatibility, radio-opacity and MRI compatibility.

## Claims

### Claim 1

A medical device comprising a biocompatible structure configured for implantation or medical intervention in a human body, wherein the medical device comprises components at least partially fabricated from a metal alloy comprising:
about 70 wt % niobium;
between 0.1 and 15 wt % tungsten;
between 0.1 and 10 wt % zirconium; and
about 5 to 29.8 wt % tantalum.

### Claim 2 (depends on 1)

The medical device according to claim 1, which is a stent.

### Claim 3 (depends on 1)

The medical device according to claim 1, which is a minimal-invasive device.

### Claim 4 (depends on 1)

The medical device according to claim 1, which is one of a catheter, a guide wire, an intra-cavernous implant, a heart repair device, and a filter.

### Claim 5 (depends on 1)

The medical device according to claim 1, wherein the metal alloy further comprises up to 5 wt % in total of at least one element selected from the group consisting of hafnium, rhenium and a lanthanide.

### Claim 6 (depends on 5)

The medical device according to claim 5, wherein the lanthanide is cerium.

### Claim 7 (depends on 1)

The medical device according to claim 1, wherein the metal alloy has a surface coated with at least one of the group consisting of a polymer, a blend of polymers, a metal, a blend of metals, a ceramic, and biomolecules.

### Claim 8 (depends on 7)

The medical device according to claim 7, wherein the surface of the metal alloy is coated by at least one biomolecule of the group consisting of peptides, proteins, lipids, carbohydrates, and nucleic acids.

### Claim 9 (depends on 1)

The medical device according to claim 1, wherein the metal alloy has a surface coated with at least one of stem cells and a bioactive substance.

### Claim 10 (depends on 9)

The medical device according to claim 9, wherein the surface of the metal alloy is coated with at least one bioactive substance of the group consisting of drugs, antibiotics, growth factors, anti-inflammatory agents, and anti-thrombogenic agents.

### Claim 11 (depends on 1)

The medical device according to claim 1, wherein the metal alloy has a surface that is passivated by oxidation or nitriding.

### Claim 12 (depends on 1)

The medical device according to claim 1, wherein the metal alloy has a surface that is one of electropolished, mechanically polished, micro-blasted, roughened, and sintered.
